ARGNF (ARGNF) Stock Price & Analysis
ARGNF (ARGNF) rose 0.00% to USD 865 as of July 25, 2026 at 06:55 UTC, according to Nexqual real-time market data.
ARGNF last closed at USD 865; the session ranged USD 803.19–803.19 on volume of 1 shares. Market capitalization is $53.79B, with a 52-week range of USD 547.6–960.58 (PNK). Source: Nexqual, July 25, 2026 at 06:55 UTC.
Key Statistics (as of July 25, 2026 at 06:55 UTC)
| Price | USD 865 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 865 |
| Open | USD 803.19 |
| Day Range | USD 803.19 – 803.19 |
| 52-Week Range | USD 547.6 – 960.58 |
| Volume | 1 shares |
| Market Cap | $53.79B |
| Exchange | PNK |
Technical Analysis (ARGNF)
Nexqual's technical model rates ARGNF "SELL" based on 1 bullish and 5 bearish signals across 124 daily candles, as of July 25, 2026 at 06:55 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 35.21 (neutral) |
| vs SMA50 | Below (USD 871.34) |
| MACD | -1.2 (negative) |
Analyst Ratings (ARGNF)
Wall Street analysts rate ARGNF "None", per Nexqual as of July 25, 2026 at 06:55 UTC.
| Consensus Rating | None |
|---|
Earnings (ARGNF)
| Next Earnings Date | 2026-10-22 |
|---|---|
| Revenue Estimate | $1.63B |
Source: Nexqual, July 25, 2026 at 06:55 UTC.
Financials & Fundamentals (ARGNF)
| Total Revenue | $5.32B |
|---|---|
| Revenue Growth (YoY) | +59.30% |
| Gross Margin | +59.07% |
| Operating Margin | +31.99% |
| Profit Margin | +32.27% |
| ROE | +23.64% |
| Debt / Equity | 0.56 |
| Current Ratio | 5.12 |
| Total Cash | $5.18B |
| Total Debt | $47.00M |
| Free Cash Flow | $761.77M |
Source: Nexqual, July 25, 2026 at 06:55 UTC.
Financial Health Score (ARGNF)
Nexqual rates ARGNF's overall financial health "Strong" across five dimensions, as of July 25, 2026 at 06:55 UTC.
| Growth | Strong — Revenue +89% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 59%, operating 32% |
| Balance Sheet | Strong — $5.18B cash vs $47M debt, net cash position |
| Cash Flow | Strong — FCF $762M, 18% margin |
| Efficiency | Strong — ROE 24%, ROA 11.6% |
Ownership (ARGNF)
| Insider Ownership | +0.02% |
|---|---|
| Institutional Ownership | +46.54% |
| Shares Outstanding | 62.19M |
| Float | 62.43M |
Source: Nexqual, July 25, 2026 at 06:55 UTC.
Leadership (ARGNF)
ARGNF is led by Karen Massey (age 46), CEO & Executive Director, per Nexqual as of July 25, 2026 at 06:55 UTC.
| CEO & Executive Director | Karen Massey (age 46) |
|---|---|
| Co-Founder & Non-Independent Non-Executive Chairman of the Board | Timothy Van Hauwermeiren EMBA, M.Sc. (age 53) |
| Chief Financial Officer | Karl Gubitz (age 55) |
| Chief Scientific Officer | Peter Ulrichts (age 45) |
| Vice President of Corporate Development & Strategy | Arjen Lemmen M.Sc. (age 40) |
Major Backers & Investors (ARGNF)
Notable institutional backers of ARGNF include Fidelity, Franklin Custodian Funds-FRANKLIN DYNATECH FUND, Prudential World Fd., Inc.-PGIM Jennison Intl Opportunities Fd., according to Nexqual as of July 25, 2026 at 06:55 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Fidelity | 0.37% |
| Franklin Custodian Funds-FRANKLIN DYNATECH FUND | 0.32% |
| Prudential World Fd., Inc.-PGIM Jennison Intl Opportunities Fd. | 0.29% |
| Federated Hermes Equity Funds-Federated Hermes Kaufmann Fund | 0.28% |
| Principal Funds, Inc-International Equity Fund | 0.23% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 5.07% |
Source: Nexqual, July 25, 2026 at 06:55 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SWZCF | SWISSCOM AG | USD 783.26 | ▲ 0% |
| ALPMF | Astellas Pharma, Inc. | USD 12.85 | ▲ 0% |
| BEIGF | BEIGENE LTD | USD 21.95 | ▲ 0% |
| DNBBY | DNB ASA | USD 31.23 | ▲ 1.07% |
| CLLNY | Cellnex Telecom SA | USD 14.63 | ▲ 3.28% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 06:55 UTC. This page is informational and not investment advice.